← Browse by Condition
Medical Condition

inflammatory bowel disease

Total Trials
8
Recruiting Now
8
Trial Phases
EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for inflammatory bowel disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — inflammatory bowel disease Clinical Trials

How many clinical trials are currently recruiting for inflammatory bowel disease?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for inflammatory bowel disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for inflammatory bowel disease?
inflammatory bowel disease research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a inflammatory bowel disease clinical trial?
Eligibility criteria for inflammatory bowel disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
National Institute of Allergy and Infectious Diseases (NIAID) 1 trial
Boston Children's Hospital 1 trial
Shanghai Pharmaceuticals Holding Co., Ltd 1 trial
Assiut University 1 trial
Janssen-Cilag G.m.b.H 1 trial

Recruiting Clinical Trials

NCT00001184
Recruiting
Immune Regulation in Ulcerative Colitis or Crohn s Disease
Enrollment
1,000 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →
NCT04331639
Recruiting
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
Enrollment
50 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT06483373 EARLY_Phase 1
Recruiting
A Clinical Study of SPH7854 Granules in Healthy Subjects.
Enrollment
111 pts
Location
China
Sponsor
Shanghai Pharmaceuticals Holdi...
View Trial →
NCT05002166
Recruiting
Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital
Enrollment
20 pts
Location
Egypt
Sponsor
Assiut University
View Trial →
NCT07102368
Recruiting
A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
Enrollment
500 pts
Location
Germany
Sponsor
Janssen-Cilag G.m.b.H
View Trial →
NCT07207200
Recruiting
Impact of Morning Light Therapy in IBD
Enrollment
30 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
View Trial →
NCT06781827
Recruiting
Research on the Use of Probiotics in the Prevention and Treatment of Inflammatory Bowel Disease
Enrollment
50 pts
Location
China
Sponsor
Wecare Probiotics Co., Ltd.
View Trial →
NCT05973500
Recruiting
Effect of Mediterranean Diet in Inflammatory Bowel Disease
Enrollment
90 pts
Location
United States
Sponsor
University of California, San ...
View Trial →

Related Conditions

ulcerative colitis (2) chrohn s disease (1) crohn disease (1) vitamin d deficiency (1) colitis ulcerative (1) crohn s disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology